A PRELIMINARY INVESTIGATION OF THE PSYCHOACTIVE AGENT 4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE - A POTENTIAL-DRUG OF ABUSE

被引：36

作者：

GLENNON, RA ^{[1
]}

TITELER, M ^{[1
]}

LYON, RA ^{[1
]}

机构：

[1] UNION UNIV ALBANY MED COLL,DEPT PHARMACOL & TOXICOL,NEIL HELLMAN LAB,ALBANY,NY 12208

来源：

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR | 1988年 / 30卷 / 03期

关键词：

D O I：

10.1016/0091-3057(88)90071-8

中图分类号：

B84 [心理学]; C [社会科学总论]; Q98 [人类学];

学科分类号：

03 ; 0303 ; 030303 ; 04 ; 0402 ;

摘要：

引用

页码：597 / 601

页数：5

共 13 条

[1]

Finney D.J, 1952, PROBIT ANAL

[2]

GLENNON RA, 1986, PSYCHOPHARMACOL BULL, V22, P953

[3] STIMULUS PROPERTIES OF 1-(3,4-METHYLENEDIOXYPHENYL)-2-AMINOPROPANE (MDA) ANALOGS [J].

GLENNON, RA ;

YOUSIF, M ;

PATRICK, G .

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1988, 29 (03) :443-449

[4] BEHAVIORAL AND SEROTONIN RECEPTOR PROPERTIES OF 4-SUBSTITUTED DERIVATIVES OF THE HALLUCINOGEN 1-(2,5-DIMETHOXYPHENYL)-2-AMINOPROPANE [J].

GLENNON, RA ;

YOUNG, R ;

BENINGTON, F ;

MORIN, RD .

JOURNAL OF MEDICINAL CHEMISTRY, 1982, 25 (10) :1163-1168

[5] N-METHYL DERIVATIVES OF THE 5-HT2 AGONIST 1-(4-BROMO-2,5-DIMETHOXYPHENYL)-2-AMINOPROPANE [J].

GLENNON, RA ;

TITELER, M ;

SEGGEL, MR ;

LYON, RA .

JOURNAL OF MEDICINAL CHEMISTRY, 1987, 30 (05) :930-932

[6] EVIDENCE FOR 5-HT2 INVOLVEMENT IN THE MECHANISM OF ACTION OF HALLUCINOGENIC AGENTS [J].

GLENNON, RA ;

TITELER, M ;

MCKENNEY, JD .

LIFE SCIENCES, 1984, 35 (25) :2505-2511

[7]

GLENNON RA, 1988, TRANSDUCTION MECHANI, P16

[8]

LYON RA, 1987, MOL PHARMACOL, V31, P194

[9]

MACPHERSON GA, 1983, COMPUT PROGRAMS BIOM, V17, P107

[10]

RAGAN FA, 1985, J ANAL TOXICOL, V9, P91, DOI 10.1093/jat/9.2.91

← 1 2 →